Furthermore, the tumours that arise in mice injected with purified CD44+CD24− LNCaP cells are phenotypically diverse, containing primarily CD44−CD24− and CD44−CD24+ cells and only a small percentage of CD44+CD24− cells, similar to tumours derived from injecting the total LNCaP cell line. This evidence concerns the gene CD24 and neoplasm.